Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

[Pravastatin and acetylsalycilic acid fixed-combination: a strategy to improve cardiovascular outcomes].

Hennekens C.

Am J Cardiovasc Drugs. 2007;7 Spec No 1:9-11. Review. French.

PMID:
19839182
[PubMed - indexed for MEDLINE]
2.

From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.

Chapman MJ.

Pharmacol Ther. 2007 Jan;113(1):184-96. Epub 2006 Sep 15. Review.

PMID:
17070923
[PubMed - indexed for MEDLINE]
3.

C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.

Li JJ, Fang CH.

Med Hypotheses. 2004;62(4):499-506.

PMID:
15050096
[PubMed - indexed for MEDLINE]
4.

Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?

Wascher TC.

Atheroscler Suppl. 2003 Dec;4(5):11-6.

PMID:
14980230
[PubMed - indexed for MEDLINE]
5.

[Interactions of statins with antithrombotic drugs].

Ruef J.

Med Klin (Munich). 2004 Feb 15;99(2):65-70. Review. German.

PMID:
14963656
[PubMed - indexed for MEDLINE]
6.

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R.

Arch Intern Med. 2004 Jan 12;164(1):40-4.

PMID:
14718320
[PubMed - indexed for MEDLINE]
7.

Current perspectives on statins.

Mishra TK, Routray S.

J Indian Med Assoc. 2003 Jun;101(6):381-3.

PMID:
14579987
[PubMed - indexed for MEDLINE]
8.

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.

Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators.

Circulation. 2003 Aug 26;108(8):921-4. Epub 2003 Aug 18.

PMID:
12925453
[PubMed - indexed for MEDLINE]
Free Article
9.

Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.

Richter WO.

Eur J Med Res. 2003 Aug 20;8(8):332-6. Review.

PMID:
12915328
[PubMed - indexed for MEDLINE]
10.
11.

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators.

JAMA. 2001 Jul 4;286(1):64-70.

PMID:
11434828
[PubMed - indexed for MEDLINE]
12.
13.

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.

Dangas G, Badimon JJ, Smith DA, Unger AH, Levine D, Shao JH, Meraj P, Fier C, Fallon JT, Ambrose JA.

J Am Coll Cardiol. 1999 Apr;33(5):1294-304.

PMID:
10193730
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.

Troche CJ, Tacke J, Hinzpeter B, Danner M, Lauterbach KW.

Eur Heart J. 1998 Apr;19 Suppl C:C59-65. Review.

PMID:
9597427
[PubMed - indexed for MEDLINE]
15.

Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.

Bertrand ME, McFadden EP, Fruchart JC, Van Belle E, Commeau P, Grollier G, Bassand JP, Machecourt J, Cassagnes J, Mossard JM, Vacheron A, Castaigne A, Danchin N, Lablanche JM.

J Am Coll Cardiol. 1997 Oct;30(4):863-9.

PMID:
9316510
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk